Published in J Trauma on December 01, 1991
Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg (1996) 2.24
Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful association to predict the development of sepsis after major trauma. PLoS One (2012) 1.13
Regulatory effects of interleukin-6 in immunoglobulin G immune-complex-induced lung injury. Am J Pathol (1997) 1.07
Inhalation injury severity and systemic immune perturbations in burned adults. Ann Surg (2013) 0.99
Interleukin-6 modulation of intestinal epithelial tight junction permeability is mediated by JNK pathway activation of claudin-2 gene. PLoS One (2014) 0.89
Early serum procalcitonin, interleukin-6, and 24-hour lactate clearance: useful indicators of septic infections in severely traumatized patients. World J Surg (2009) 0.89
Reduction of burn progression with topical delivery of (antitumor necrosis factor-α)-hyaluronic acid conjugates. Wound Repair Regen (2012) 0.87
Thermal injury induces the development of inflammatory macrophages from nonadherent bone marrow cells. Inflammation (1997) 0.86
Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis? World J Exp Med (2015) 0.85
Induction and suppression of cytokine release (tumour necrosis factor-alpha; interleukin-6, interleukin-1 beta) by Escherichia coli pathogenicity factors (adhesions, alpha-haemolysin). Immunology (1993) 0.83
Survival and cell mediated immunity after burn injury in aged mice. J Am Aging Assoc (2002) 0.82
Low molecular weight heparin-induced pharmacological modulation of burn wound healing. Ann Burns Fire Disasters (2006) 0.81
The effective removal of proinflammatory cytokines by continuous hemofiltration with a polymethylmethacrylate membrane following severe burn injury: report of three cases. Surg Today (1999) 0.78
Protective effect of Verapamil on hepatic ischemia-reperfusion injury during hepatectomy in the cirrhotic patients with hepatocellular carcinoma. Langenbecks Arch Surg (2009) 0.78
Clinical chorioamnionitis at term IV: the maternal plasma cytokine profile. J Perinat Med (2016) 0.77
Calcium-Sensing Receptor Gene: Regulation of Expression. Front Physiol (2016) 0.76
Prostaglandin E2 mediates growth arrest in NFS-60 cells by down-regulating interleukin-6 receptor expression. Biochem J (2003) 0.75
Rationale, design and performance of a clinical trial to investigate interferon-gamma (Imukin) in the prophylactic treatment of severe burns-related infections. Intensive Care Med (1996) 0.75
[A new method for synthesis of peptides: activation of the carboxyl group with dicyclohexylcarbodiimide using 1-hydroxybenzotriazoles as additives]. Chem Ber (1970) 3.77
Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharmacol (1991) 3.60
The structure of the first coordination shell in liquid water. Science (2004) 3.31
Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br J Pharmacol (1991) 2.72
Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. Science (1999) 2.62
Absence of Mn-centered oxidation in the S(2) --> S(3) transition: implications for the mechanism of photosynthetic water oxidation. J Am Chem Soc (2001) 2.51
The inhomogeneous structure of water at ambient conditions. Proc Natl Acad Sci U S A (2009) 2.31
Rhodopsin mutants that bind but fail to activate transducin. Science (1990) 2.16
Trace metals as biomarkers for eumelanin pigment in the fossil record. Science (2011) 2.13
Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis (1995) 1.97
Complement-dependent B-cell activation by cobra venom factor and other mitogens? J Exp Med (1974) 1.97
Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology (1994) 1.81
Role of Escherichia coli alpha-hemolysin and bacterial adherence in infection: requirement for release of inflammatory mediators from granulocytes and mast cells. Infect Immun (1986) 1.70
Ability of the T cell-replacing polyanion dextran sulfate to trigger the alternate pathway of complement activation. Eur J Immunol (1973) 1.68
Release of leukotriene C4 from human polymorphonuclear leucocytes as determined by radioimmunoassay. FEBS Lett (1982) 1.66
Myocardial bridges: morphological and functional aspects. Br Heart J (1991) 1.64
Emergence of a community-associated methicillin-resistant Staphylococcus aureus strain with a unique resistance profile in Southwest Nigeria. J Clin Microbiol (2009) 1.62
Bacterial adherence and hemolysin production from Escherichia coli induces histamine and leukotriene release from various cells. Infect Immun (1985) 1.61
Mitochondrial DNA (mtDNA) reveals that female Bechstein's bats live in closed societies. Mol Ecol (2000) 1.53
Serum CD14 levels in polytraumatized and severely burned patients. Clin Exp Immunol (1991) 1.50
Can the new RCP R0/R1 classification predict the clinical outcome in ductal adenocarcinoma of the pancreatic head? Langenbecks Arch Surg (2012) 1.49
Bypass-activation of the complement system starting with C3. I. Generation and function of an enzyme from a factor of guinea-pig serum and cobra venom. Immunology (1972) 1.47
Genetic classification and distinguishing of Staphylococcus species based on different partial gap, 16S rRNA, hsp60, rpoB, sodA, and tuf gene sequences. J Clin Microbiol (2008) 1.47
Mechanism of action of the phorbol ester tumor promoters: specific receptors for lipophilic ligands. Biochem Pharmacol (1984) 1.46
Cetirizine counter-regulates interleukin-8 release from human epithelial cells (A549) Clin Exp Allergy (1999) 1.45
DNP-antigens activate the alternate pathway of the complement system. J Immunol (1974) 1.44
X-ray Monochromator with 2 x 10(8) Energy Resolution. J Synchrotron Radiat (1996) 1.44
Activation of human effector cells by different bacterial toxins (leukocidin, alveolysin, and erythrogenic toxin A): generation of interleukin-8. Infect Immun (1994) 1.44
Mn K-edge XANES and Kbeta XES studies of two Mn-oxo binuclear complexes: investigation of three different oxidation states relevant to the oxygen-evolving complex of photosystem II. J Am Chem Soc (2001) 1.40
[Heavy metal pollution of soil and garden products of Stolberg home gardens and lead and cadmium pollution of small farms in Stolberg]. Gesundheitswesen (1993) 1.39
Effect of thiol-activated toxins (streptolysin O, alveolysin, and theta toxin) on the generation of leukotrienes and leukotriene-inducing and -metabolizing enzymes from human polymorphonuclear granulocytes. Infect Immun (1985) 1.34
Comparative study using various methods for identification of Staphylococcus species in clinical specimens. J Clin Microbiol (2006) 1.33
Leukotriene B4 generation and DNA fragmentation induced by leukocidin from Staphylococcus aureus: protective role of granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF for human neutrophils. Infect Immun (1994) 1.32
Crystal structure of Mip, a prolylisomerase from Legionella pneumophila. Nat Struct Biol (2001) 1.31
Generation of leukotrienes from human granulocytes by alveolysin from Bacillus alvei. Infect Immun (1984) 1.30
Arachidonic acid metabolites from polymorphonuclear leukocytes of healthy donors, severely burned patients and children with cystic fibrosis--routine monitoring by high-performance liquid chromatography. J Chromatogr (1988) 1.30
Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A23187. J Immunol (1976) 1.27
Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer. Cancer Res (1998) 1.24
Structure of the human macrophage MARCO receptor and characterization of its bacteria-binding region. J Biol Chem (1998) 1.23
Eosinophil chemotactic factor (ECF). II. Release from human polymorphonuclear leukocytes during phagocytosis. J Immunol (1976) 1.22
Higher heart rate of laboratory mice housed individually vs in pairs. Lab Anim (2003) 1.22
Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem (1997) 1.19
Comparison of four hemolysin-producing organisms (Escherichia coli, Serratia marcescens, Aeromonas hydrophila, and Listeria monocytogenes) for release of inflammatory mediators from various cells. J Clin Microbiol (1988) 1.19
The multimerization state of retroviral RNA is modulated by ammonium ions and affects HIV-1 full-length cDNA synthesis in vitro. Nucleic Acids Res (1993) 1.17
Prevalence and spread of enterohepatic Helicobacter species in mice reared in a specific-pathogen-free animal facility. J Clin Microbiol (2006) 1.17
Rapid ribosequencing--an effective diagnostic tool for detecting microbial infection. Infection (2001) 1.16
Generation and secretion of eosinophilotactic activity from human polymorphonuclear neutrophils by various mechanisms of cell activation. Immunology (1979) 1.16
Subtyping of ST22-MRSA-IV (Barnim epidemic MRSA strain) at a university clinic in Germany from 2002 to 2005. J Med Microbiol (2007) 1.15
Heterogeneity of methicillin-susceptible Staphylococcus aureus strains at a German University Hospital implicates the circulating-strain pool as a potential source of emerging methicillin-resistant S. aureus clones. J Clin Microbiol (2006) 1.14
Generation of leukotrienes and lipoxygenase factors from human polymorphonuclear granulocytes during bacterial phagocytosis and interaction with bacterial exotoxins. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 1.14
Analysis of bypass activation of C3 by endotoxic LPS and loss of this potency. Immunology (1973) 1.13
Total parenteral nutrition with glutamine dipeptide after major abdominal surgery: a randomized, double-blind, controlled study. Ann Surg (1998) 1.12
Impact of omega-3 fatty acid enriched TPN on leukotriene synthesis by leukocytes after major surgery. Clin Nutr (2003) 1.10
Factor D in the alternate pathway of complement activation: purification, physicochemical characterization and functional role. Immunochemistry (1974) 1.09
Metabolism of leukotriene B4 by activated human polymorphonuclear granulocytes. Immunology (1988) 1.09
Primary structure, developmental expression, and immunolocalization of the murine laminin alpha4 chain. J Biol Chem (1997) 1.09
Influence of a total parenteral nutrition enriched with omega-3 fatty acids on leukotriene synthesis of peripheral leukocytes and systemic cytokine levels in patients with major surgery. J Trauma (1997) 1.09
Binding of rat IgE with the subcellular components of normal rat mast cells. Immunochemistry (1976) 1.08
[Indications for laparoscopic pancreas operations: results of a consensus conference and the previous laparoscopic pancreas register]. Chirurg (2012) 1.07
Metabolism of leukotrienes by L-gamma-glutamyl-transpeptidase and dipeptidase from human polymorphonuclear granulocytes. Immunology (1985) 1.07
The metabolism of leukotrienes in blood plasma studied by high-performance liquid chromatography. Biochim Biophys Acta (1985) 1.06
[A new method for the synthesis of peptides: activation of the carboxy group with dicyclohexylcarbodiimide and 3-hydroxy-4-oxo-3,4-dihydro-1,2,3-benzotriazine]. Chem Ber (1970) 1.06
Induction of inflammatory mediators (histamine and leukotrienes) from rat peritoneal mast cells and human granulocytes by Pseudomonas aeruginosa strains from burn patients. Infect Immun (1989) 1.06
Role of Pseudomonas aeruginosa lipase in inflammatory mediator release from human inflammatory effector cells (platelets, granulocytes, and monocytes. Infect Immun (1996) 1.06
Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium. J Clin Microbiol (2008) 1.06
Effect of respiratory syncytial virus-antibody complexes on cytokine (IL-8, IL-6, TNF-alpha) release and respiratory burst in human granulocytes. Immunology (1994) 1.06
Signal transduction in human platelets and inflammatory mediator release induced by genetically cloned hemolysin-positive and -negative Escherichia coli strains. Infect Immun (1990) 1.05
[Racemization in peptide syntheses]. Chem Ber (1970) 1.04
Expression of low-affinity receptor for IgE (Fc epsilon RII, CD23) and IgE-BF (soluble CD23) release by lymphoblastoid B-cell line RPMI-8866 and human peripheral lymphocytes of normal and atopic donors. Immunology (1989) 1.03
Generation and release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by arachidonic acid. Eur J Immunol (1978) 1.02
Immunologic properties of mast cells from rats infected with Nippostrongylus brasiliensis. J Immunol (1975) 1.02
Three-dimensional structure of human tissue inhibitor of metalloproteinases-2 at 2.1 A resolution. J Mol Biol (1998) 1.01
Effect of sodium fluoride on the generation of lipoxygenase products from human polymorphonuclear granulocytes, mononuclear cells and platelets--indication for the involvement of G proteins. Immunology (1989) 1.01
Prevalence of Helicobacter pylori resistance to several antimicrobial agents in a region of Germany. Eur J Clin Microbiol Infect Dis (1998) 1.00
Generation of slow-reacting substance (leukotrienes) by endotoxin and lipid A from human polymorphonuclear granulocytes. Immunology (1984) 1.00
Comparison of the performance of the rapid antigen detection actim Influenza A&B test and RT-PCR in different respiratory specimens. J Med Microbiol (2009) 1.00
Induction of inflammatory mediators from human polymorphonuclear granulocytes and rat mast cells by haemolysin-positive and -negative E. coli strains with different adhesins. Immunology (1986) 1.00
A high resolution and large solid angle x-ray Raman spectroscopy end-station at the Stanford Synchrotron Radiation Lightsource. Rev Sci Instrum (2012) 0.99
Infrared mapping resolves soft tissue preservation in 50 million year-old reptile skin. Proc Biol Sci (2011) 0.99
The differential expression of proinflammatory cytokines IL-6, IL-8 and TNF-alpha in renal cell carcinoma. Anticancer Res (1999) 0.98
Beta-D-Galactoside transport in Escherichia coli: Mr determination of the transport protein in organic solvent. FEBS Lett (1982) 0.98
Specific binding of mouse IgE with rat mast cells. J Immunol (1974) 0.98
[Accuracy of CT-based navitation of pedicle screws in the thoracic spine compared with conventional technique]. Unfallchirurg (2004) 0.98
Cytokine (IL-8, IL-6, TNF-alpha) and soluble TNF receptor-I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection. Immunology (1995) 0.97
99mTc-DTPA aerosol for same-day post-perfusion ventilation imaging: results of a multicentre study. Eur J Nucl Med (1993) 0.97
Induction and comparison of the eosinophil chemotactic factor with endogenous hydroxyeicosatetraenoic acids: its inhibition by arachidonic acid analogs. Adv Prostaglandin Thromboxane Leukot Res (1982) 0.97